Accelrys Acquires Cloud-Based Solution
A web-based portal, HEOS provides access to chemical registration, biological assay results, computational and visual analytics, safety assessment and pharmacokinetics data, and other project information. The purchase is part of a 2011 strategic agreement that enabled Accelrys to sell HEOS as part of its Cheminformatics Suite.
San Diego, CA 5/17/12—Accelrys has acquired the Hit Explorer Operating System (HEOS), including supporting personnel, from drug discovery and development firm SCYNEXIS. HEOS is a Software-as-a-Service workspace that streamlines collaborative drug discovery. “As many of our customers move to multi-site, multi-collaborator projects to accelerate innovation and reduce costs, we look forward to broadening the applicability and reach of HEOS as a secure, easy-to-use, Cloud-based information management workspace for the wider scientific community,” commented Accelrys President and CEO Max Carnecchia.
